REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/13/2025
Back to search
Official data from USPTO
FIDELIS PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FIDELIS PHARMACEUTICALS
ST13
US500000086760833Class
42
Filing
86760833
Registration
5039296
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
09/14/2025
Trademark type
Word
Nice classes
42
Filing date
09/18/2015
Registration date
09/13/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/11/2022
Last transaction
09/14/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
09/01/2015
First use in commerce
09/01/2015
Drawing code
4
Owner type
03
Owner location
NORTH BRUNSWICK, NJ
Examiner
SOBRAL, CHRISTINA
Law office
L90
Current location
TMEG LAW OFFICE 109
Holders and representatives
Holders
FIDELIS ANIMAL HEALTH, INC.
FIDELIS PHARMACEUTICALS, INC.
Fidelis Pharmaceuticals, LLC
Fidelis Pharmaceuticals, LLC
Representatives
Frederic M. Wilf Wilftek LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of pharmaceutical preparations and medicines
Publications
History of USPTO decisions and trademark events.
28 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/11/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/11/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/11/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/22/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/29/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/13/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/28/2016
PUBO
PUBLISHED FOR OPPOSITION
06/28/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/08/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/19/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/19/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/19/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2016
GNRT
NON-FINAL ACTION E-MAILED
01/06/2016
CNRT
NON-FINAL ACTION WRITTEN
01/06/2016
DOCK
ASSIGNED TO EXAMINER
01/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/22/2015
NWAP
NEW APPLICATION ENTERED
09/22/2015
Continuous trademark protection
Get notified about every new filing that threatens FIDELIS PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.